Author:
Tagliatela Alicia C.,Hempstead Stephanie C.,Hibshman Priya S.,Hockenberry Max A.,Brighton Hailey E.,Pecot Chad V.,Bear James E.
Abstract
AbstractCoronin 1C is overexpressed in multiple tumors, leading to the widely held view that this gene drives tumor progression, but this hypothesis has not been rigorously tested in melanoma. Here, we combined a conditional knockout of Coronin 1C with a genetically engineered mouse model of PTEN/BRAF-driven melanoma. Loss of Coronin 1C in this model increases both primary tumor growth rates and distant metastases. Coronin 1C-null cells isolated from this model are more invasive in vitro and produce more metastatic lesions in orthotopic transplants than Coronin 1C-reexpressing cells due to the shedding of extracellular vesicles (EVs) containing MT1-MMP. Interestingly, these vesicles contain melanosome markers suggesting a melanoma-specific mechanism of EV release, regulated by Coronin 1C, that contributes to the high rates of metastasis in melanoma.
Publisher
Springer Science and Business Media LLC
Reference98 articles.
1. Domingues, B., Lopes, J. M., Soares, P. & Pópulo, H. Melanoma treatment in review. Immunotargets Ther. 7, 35–49 (2018).
2. Leonardi, G. C. et al. Cutaneous melanoma: From pathogenesis to therapy (review). Int. J. Oncol. 52, 1071–1080 (2018).
3. Rabbie, R., Ferguson, P., Molina-Aguilar, C., Adams, D. J. & Robles-Espinoza, C. D. Melanoma subtypes: Genomic profiles, prognostic molecular markers and therapeutic possibilities. J. Pathol. 247, 539–551 (2019).
4. Reddy, B. Y., Miller, D. M. & Tsao, H. Somatic driver mutations in melanoma. Cancer 123, 2104–2117 (2017).
5. Tsao, H., Goel, V., Wu, H., Yang, G. & Haluska, F. G. Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma. J. Invest. Dermatol. (London) 122, 337–341 (2004).
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献